Cargando…
Computer-Based De Novo Designs of Tripeptides as Novel Neuraminidase Inhibitors
The latest influenza A (H1N1) pandemic attracted worldwide attention and called for the urgent development of novel antiviral drugs. Here, seven tripeptides are designed and explored as neuraminidase (NA) inhibitors on the structural basis of known inhibitors. Their interactions with NA are studied...
Autores principales: | Yang, Zhiwei, Yang, Gang, Zu, Yuangang, Fu, Yujie, Zhou, Lijun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100827/ https://www.ncbi.nlm.nih.gov/pubmed/21614183 http://dx.doi.org/10.3390/ijms11124932 |
Ejemplares similares
-
Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design
por: Zhu, Qinchang, et al.
Publicado: (2015) -
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors
por: Vernieri, Ermelinda, et al.
Publicado: (2013) -
Comparative Anti-Infectious Bronchitis Virus (IBV) Activity of (-)-Pinene: Effect on Nucleocapsid (N) Protein
por: Yang, Zhiwei, et al.
Publicado: (2011) -
QSAR Study on Antioxidant Tripeptides and the Antioxidant Activity of the Designed Tripeptides in Free Radical Systems
por: Chen, Nan, et al.
Publicado: (2018) -
Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors
por: Li, Ping, et al.
Publicado: (2020)